# Turning Point Brands, Inc.: Form 10-Q for the period ended Jun 30, 2019

- Company: [Turning Point Brands, Inc.](/companies/tpb.md) (CIK 1290677)
- Form: 10-Q
- Filed: 2019-08-01
- Accepted by EDGAR: Aug 1, 2019, 15:13 ET
- Period: 2019-06-30
- Accession: 0001140361-19-013997
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1290677/000114036119013997/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1290677/000114036119013997/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-04-01 to 2019-06-30 | $93.3m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months, 2019-01-01 to 2019-06-30 | $185.0m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months, 2019-04-01 to 2019-06-30 | $52.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2019-01-01 to 2019-06-30 | $103.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-04-01 to 2019-06-30 | $41.2m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2019-01-01 to 2019-06-30 | $81.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2019-04-01 to 2019-06-30 | $21.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2019-01-01 to 2019-06-30 | $49.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-04-01 to 2019-06-30 | $19.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2019-01-01 to 2019-06-30 | $32.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2019-04-01 to 2019-06-30 | $3.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2019-01-01 to 2019-06-30 | $4.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-04-01 to 2019-06-30 | $13.2m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2019-01-01 to 2019-06-30 | $19.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-04-01 to 2019-06-30 | $0.66 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2019-01-01 to 2019-06-30 | $0.99 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-04-01 to 2019-06-30 | $0.67 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2019-01-01 to 2019-06-30 | $1.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-04-01 to 2019-06-30 | 20,131,980 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2019-01-01 to 2019-06-30 | 19,895,959 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2019-01-01 to 2019-06-30 | $21.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2019-04-01 to 2019-06-30 | $1.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months, 2019-01-01 to 2019-06-30 | $2.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2019-01-01 to 2019-06-30 | $1.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2019-06-30 | $2.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-06-30 | $121.2m | us-gaap:AssetsCurrent |
| Total assets | at 2019-06-30 | $361.3m | us-gaap:Assets |
| Current liabilities | at 2019-06-30 | $67.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-06-30 | $259.3m | us-gaap:Liabilities |
| Long-term debt | at 2019-06-30 | $173.6m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2019-06-30 | $102.0m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 42,930 characters.

*You should read the following discussion of the historical financial condition and results of operations in conjunction with our historical consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements subject to risks and uncertainties that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”*

*The following discussion relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this Quarterly Report on Form 10-Q. In this discussion, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. We were incorporated in 2004 under the name North Atlantic Holding Company, Inc. On November 4, 2015, we changed our name to Turning Point Brands, Inc. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.*

### Organizational Structure

We, Turning Point Brands, Inc., are a holding company which owns North Atlantic Trading Company, Inc. (“NATC”), and its subsidiaries, Turning Point Brands, LLC (“TPLLC”), and its subsidiaries, and Turning Point Brands (Canada) Inc. (“TPBC”). NATC includes subsidiaries National Tobacco Company, L.P. (“NTC”), National Tobacco Finance, LLC (“NTFLLC”), North Atlantic Operating Company, Inc. (“NAOC”), North Atlantic Cigarette Company, Inc. (“NACC”), and RBJ Sales, Inc. (“RBJ”). TPLLC includes subsidiaries Intrepid Brands, LLC (“Intrepid”), Vapor Beast, LLC (“VaporBeast”, f/k/a Smoke Free Technologies, Inc.), Vapor Shark, LLC, and its subsidiaries (collectively, “Vapor Shark”, f/k/a The Hand Media), Vapor Acquisitions Company, LLC (“Vapor Supply”), Vapor Finance, LLC (“VFIN”), International Vapor Group, LLC and its subsidiaries (collectively, “IVG”), and Nu-X Ventures, LLC (“Nu-X”).

### Overview

Turning Point Brands, Inc. (the “Company,” “we,” “our,” or “us”) is a leading, independent provider of Other Tobacco Products (“OTP”) and adult consumer alternatives. We estimate the OTP industry generated approximately $11 billion of manufacturer revenue in 2018. In contrast to manufactured cigarettes, which have been experiencing declining volumes for decades based on data published by the Alcohol and Tobacco Tax and Trade Bureau (“TTB”), the OTP industry is demonstrating increased consumer appeal with low to mid-single digit consumer unit growth as reported by Management Science Associates, Inc. (“MSAi”), a third-party analytics and information company. We were the 6th largest competitor in terms of total OTP consumer units sold during 2018. We sell a wide range of products across the OTP spectrum; however, we do not sell cigarettes. Our portfolio of brands includes some of the most widely recognized names in the OTP industry, such as *Zig-Zag®, Beech-Nut®, Stoker’s®, Trophy®, VaporBeast®* and *VaporFi®*. We currently ship to approximately 800 distributors with an additional 100 secondary, indirect wholesalers in the U.S. that carry and sell our products. We operate in three segments: (i) Smokeless products, (ii) Smoking products, and (iii) NewGen products. Under the leadership of a senior management team with an average of 23 years of experience in the tobacco industry, we have grown and diversified our business through new product launches, category expansions, and acquisitions while concurrently improving operational efficiency.

We have identified additional growth opportunities in the emerging alternatives market. In January 2019, we established our subsidiary, Nu-X Ventures (“Nu-X”), a new company and wholly-owned subsidiary dedicated to the development, production and sale of alternative products and acquisitions in related spaces. The creation of Nu-X allows TPB to leverage its expertise in traditional OTP management to alternative products. The TPB management team has over 100 years of experience navigating federal, state and local regulations that are directly applicable to the growing alternatives market. In November 2018, we acquired a minority stake in Canadian American Standard Hemp Inc. (“CASH”). The investment in CASH positions us to meaningfully participate in the market for hemp-derived products. Through our investment in CASH, we have access to CASH’s proprietary extraction processes enabling the harvest of cannabinoids for use in the creation and distribution of high-quality hemp-derived products. The CASH investment is part of Nu-X and we plan to make additional investments, partnerships and acquisitions to drive the business of Nu-X. These endeavors will enable us to continue to identify unmet customer needs and provide quality products that we believe will result in genuine customer satisfaction and foster the growth of revenue.

We believe there are meaningful opportunities to grow through acquisitions and joint ventures across all product categories. As of December 31, 2018, our products are available in approximately 185,000 U.S. retail locations which, with the addition of retail stores in Canada, brings our total North American retail presence to an estimated 210,000 points of distribution. Our sales team targets widespread distribution to all traditional retail channels, including convenience stores.

#### Products

We operate in three segments: Smokeless products, Smoking products and NewGen products. In our Smokeless products segment, we (i) manufacture and market moist snuff and (ii) contract for and market loose leaf chewing tobacco products. In our Smoking products segment, we (i) market and distribute cigarette papers, tubes, and related products; (ii) market and distribute finished cigars and MYO cigar wraps; and (iii) process, package, market, and distribute traditional pipe tobaccos. In our NewGen products segment, we (i) market and distribute e-cigarettes, e-liquids, vaporizers, and certain other products without tobacco and/or nicotine; (ii) distribute a wide assortment of vaping and CBD related products to non-traditional retail via VaporBeast, Vapor Shark, Vapor Supply, and IVG; and (iii) distribute a wide assortment of vaping and CBD related products to individual consumers via Vapor Shark, Vapor World, and VaporFi branded retail outlets in addition to online platforms. Our portfolio of brands includes some of the most widely recognized names in the OTP industry such as *Stoker’s®* in the Smokeless segment, *Zig-Zag®* in the Smoking segment, and *VaporBeast®* and *VaporFi®* in the NewGen segment.

#### Operations

Our core tobacco business (Smokeless and Smoking segments) primarily generates revenues from the sale of our products to wholesale distributors who, in turn, resell the products to retail operations. Our acquisition of VaporBeast in the fourth quarter of 2016 expanded our revenue streams as we began selling directly to non-traditional retail outlets. Our acquisitions of Vapor Shark in the second quarter of 2017 and Vapor Supply in the second quarter of 2018 further expanded our selling network by allowing us to directly reach ultimate consumers through Vapor Shark and Vapor World branded retail outlets, respectively. Our acquisition of IVG in the third quarter of 2018 enhanced our business-to-consumer revenue stream with the addition of Vapor-Fi branded retail outlets accompanying a robust online platform headlined by VaporFi.com and DirectVapor.com. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.

We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. Approximately 85% of our production, as measured by net sales, is outsourced to suppliers. The remaining production consists of our moist snuff tobacco operations located in Dresden, Tennessee, and Louisville, Kentucky; the packaging of our pipe tobacco in Louisville, Kentucky; and the proprietary e-liquids operations located in Louisville, Kentucky, and Miami, Florida. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel. Our other principal expenses include interest expense and other expenses.

### Key Factors Affecting Our Results of Operations

We consider the following to be the key factors affecting our results of operations:

- Our ability to further penetrate markets with our existing products;
- Our ability to introduce new products and product lines that complement our core business;
- Decreasing interest in some tobacco products among consumers;
- Price sensitivity in our end-markets;
- Marketing and promotional initiatives, which cause variability in our results;
- General economic conditions, including consumer access to disposable income;
- Cost and increasing regulation of promotional and advertising activities;
- Cost of complying with regulation, including the Remedy Order;
- Counterfeit and other illegal products in our end-markets;
- Currency fluctuations;
- Our ability to identify attractive acquisition opportunities in OTP; and
- Our ability to integrate acquisitions.

### Recent Developments

#### Solace Technologies Acquisition

In July 2019, we acquired Solace Technologies (“Solace”) for $10.56 million in total consideration, comprised of $8.25 million in cash and $2.31 million restricted stock earn out based on Solace performance and $4.62 million of our performance based restricted stock units to former owners who became employees. Solace is an innovative product development company that has grown from the creator of one of the leading vape juice brands in the industry into a leader of alternative ingredients product development. We intend to incorporate Solace’s innovative products as well as the legacy vapor products into our Nu-X Ventures development engine.

#### ReCreation Marketing Investment

In July 2019 we obtained a 30% stake in Canadian distribution entity, ReCreation Marketing (“ReCreation”). We will invest $3 million through our newly-created subsidiary, Turning Point Brands (Canada) Inc. into ReCreation, with options to acquire up to a 50% ownership position. We will receive board seats aligned with our ownership position.

ReCreation Marketing is a specialty marketing and distribution firm focused on building brands in the Canadian smoking and vaping categories. ReCreation’s management has significant expertise in marketing and distributing tobacco and cannabis products throughout Canada. ReCreation’s management and advisory team has over 50 years combined experience building and managing a portfolio of premium brands, all supported by an expert team of sales associates working across Canada to provide service to over 30,000 traditional retail outlets and newly-constructed cannabis dispensaries. ReCreation also supports RoseLife Science, a leading cannabis product innovator, producer, service provider and marketer located in Québec.

#### Convertible Notes Offering

In July 2019, we issued $150.0 million in aggregate principal amount of our 2.50% convertible senior notes due July 15, 2024 (the “notes”) in a transaction exempt from registration under the Securities Act pursuant to Rule 144A. In addition, we granted the initial purchasers a 13-day option to purchase up to an additional $22.5 million in aggregate principal amount of the notes on the same terms and conditions. This option was exercised in full during July 2019. The net proceeds were used to prepay all amounts outstanding under the 2018 Second Lien Term Loan, as well as to pay approximately $20.53 million for the cost of entering into the capped call transactions as described below. Any remaining net proceeds from the offering were allocated for general corporate purposes, including acquisitions that are yet to be identified.

The convertible notes are convertible, under certain conditions, at an initial exchange rate of 18.567 shares of our voting common stock per $1,000 principal amount of notes (equivalent to an initial exchange price of approximately $53.86 per share). Upon any conversion, we will settle its exchange obligation in cash, shares of common stock, or a combination of cash and shares, at our election.

In connection with the convertible notes offering, we entered into privately negotiated capped call transactions with certain financial institutions (the “option counterparties”). The capped call transactions are expected to reduce potential dilution to shares of our common stock and/or offset potential cash payments we are required to make in excess of the principal amount upon any conversion of the convertible notes. Such reduction and/or offset is subject to a cap representing a price per share of $82.86, a 100.0% premium over our last reported sale price of $41.43 per common share on the NYSE on July 25, 2019.

In connection with the offering we entered into a First Amendment (the “Amendment”) to our First Lien Credit Agreement (the “Credit Agreement”), with Fifth Third Bank, as administrative agent, and other lenders and certain other lender parties thereto. The Amendment was entered into primarily to permit us to issue up to $200 million of convertible senior notes, enter into certain capped call transactions in connection with the issuance of such notes and to use the proceeds from the issuance of the notes to repay amounts outstanding under the Company’s second lien credit agreement and use the remaining proceeds for acquisitions and investments. The Amendment also amends (i) the consolidated total leverage ratio covenant to 5.5 with step-downs to 5.0 to reflect the issuance of the notes and (ii) the consolidated senior leverage ratio covenant to 2.0 with step-downs to 2.5 to reflect the prepayment of indebtedness under its second lien credit agreement.

### Critical Accounting Policies and Uses of Estimates

There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2018 Annual Report on Form 10-K.

### Recent Accounting Pronouncements

Refer to Note 2, “Summary of Significant Accounting Policies”, of Notes to Consolidated Financial Statements included in this Quarterly Report for a description of recently issued accounting pronouncements, including those recently adopted.

### Results of Operations

#### Comparison of the Three Months Ended June 30, 2019, to the Three Months Ended June 30, 2018

The table and discussion set forth below displays our consolidated results of operations (in thousands):

| Consolidated Results of Operations Data: Net sales | Three Months Ended June 30, 2019 | 2018 | % Change |
| --- | ---: | ---: | ---: |
| Smokeless products | $26,176 | $24,410 | 7.2% |
| Smoking products | 25,363 | 29,328 | -13.5% |
| NewGen products | 41,800 | 27,363 | 52.8% |
| Total net sales | 93,339 | 81,101 | 15.1% |
| Cost of sales | 52,156 | 45,306 | 15.1% |
| Gross profit |  |  |  |
| Smokeless products | 14,063 | 12,533 | 12.2% |
| Smoking products | 13,738 | 15,180 | -9.5% |
| NewGen products | 13,382 | 8,082 | 65.6% |
| Total gross profit | 41,183 | 35,795 | 15.1% |
| Selling, general, and administrative expenses | 21,242 | 20,993 | 1.2% |
| Operating income | 19,941 | 14,802 | 34.7% |
| Interest expense, net | 3,736 | 3,455 | 8.1% |
| Investment Income | (118) | (144) | -18.1% |
| Loss on extinguishment of debt | 150 | - | NM |
| Net periodic benefit (income), excluding service cost | (11) | 264 | -104.2% |
| Income before income taxes | 16,184 | 11,227 | 44.2% |
| Income tax expense | 2,979 | 1,908 | 56.1% |
| Consolidated net income | $13,205 | $9,319 | 41.7% |

**Net Sales:** For the three months ended June 30, 2019, consolidated net sales increased to $93.3 million from $81.1 million for the three months ended June 30, 2018, an increase of $12.2 million or 15.1%. The increase in net sales was primarily driven by volume growth in NewGen which includes the addition of IVG sales in 2019.

For the three months ended June 30, 2019, net sales in the Smokeless products segment increased to $26.2 million from $24.4 million for the three months ended June 30, 2018, an increase of $1.8 million or 7.2%. For the three months ended June 30, 2019, volume increased 3.1% and price/mix increased 4.1%. The increase in net sales was primarily driven by the continuing double-digit volume growth of *Stoker’s®* MST partially offset by declining sales in chewing tobacco, largely attributable to long-term segment erosion, and a continuing shift to lower price products.

For the three months ended June 30, 2019, net sales in the Smoking products segment decreased to $25.4 million from $29.3 million for the three months ended June 30, 2018, a decrease of $4.0 million or 13.5%. For the three months ended June 30, 2019, volume decreased 13.9% and price/mix increased 0.4%. The net sales decline is principally attributable to the continued delay of Canadian paper orders as a result of new packaging regulations in the country and declining sales in the low-margin cigars business.

For the three months ended June 30, 2019, net sales in the NewGen products segment increased to $41.8 million from $27.4 million for the three months ended June 30, 2018, an increase of $14.4 million or 52.8%. The increase in net sales was primarily driven by $4.3 million of Nu-X alternative products sales in the quarter and the addition of IVG net sales in 2019.

**Gross Profit:** For the three months ended June 30, 2019, consolidated gross profit increased to $41.2 million from $35.8 million for the three months ended June 30, 2018, an increase of $5.4 million or 15.1%. Gross profit as a percentage of revenue remained flat at 44.1% for the three months ended June 30, 2019, with the same percentage for the three months ended June 30, 2018.

For the three months ended June 30, 2019, gross profit in the Smokeless products segment increased to $14.1 million from $12.5 million for the three months ended June 30, 2018, an increase of $1.5 million or 12.2%. Gross profit as a percentage of net sales increased to 53.7% of net sales for the three months ended June 30, 2019, from 51.3% of net sales for the three months ended June 30, 2018, primarily as a result of increased MST volume.

For the three months ended June 30, 2019, gross profit in the Smoking products segment decreased to $13.7 million from $15.2 million for the three months ended June 30, 2018, a decrease of $1.4 million or 9.5%. Gross profit as a percentage of net sales increased to 54.2% of net sales for the three months ended June 30, 2019, from 51.8% of net sales for the three months ended June 30, 2018, as a result of the delay of Canadian paper sales and a continued decline in the low margin cigar business. For the three months ended June 30, 2019 cigar sales were $0.9 million compared to $1.3 million for the three months ended June 30, 2018.

For the three months ended June 30, 2019, gross profit in the NewGen products segment increased to $13.4 million from $8.1 million for the three months ended June 30, 2018, an increase of $5.3 million or 65.6%. Gross profit as a percentage of net sales increased to 32.0% of net sales for the three months ended June 30, 2019, from 29.5% of net sales for the three months ended June 30, 2018, primarily as a result of the addition of proprietary Nu-X CBD and IVG, a business-to-consumer operation which generally has higher margins. For the three months ended June 30, 2019, gross profit included $2.0 million of tariff expenses.

**Selling, General, and Administrative Expenses:** For the three months ended June 30, 2019, selling, general, and administrative expenses increased to $21.2 million from $21.0 million for the three months ended June 30, 2018, an increase of $0.2 million or 1.2%. Selling, general and administrative expenses included $5.0 million of expense relating to the inclusion of three months of IVG activity, $0.2 million for one month of Vapor Supply activity, $0. million of severance related expenses for organizational changes and $1.3 million of new product launch costs for Nu-X products. The increased expenses are offset by a net $5.5 million gain related to the settlement of the VMR Distribution and Supply agreement (VMR Agreement) during the second quarter 2019. Refer to Note 17, “Legal Settlement”, of Notes to Consolidated Financial Statements for additional information on the settlement. In addition, there was $0.8 million less transactional costs (including an earnout for IVG management) for three months ended June 30, 2019 as compared to three months ended June 20, 2018.

**Interest Expense, net:** For the three months ended June 30, 2019, interest expense increased to $3.7 million from $3.5 million for the three months ended June 30, 2018, as a result of higher interest rates in the second quarter 2019 for the 2018 Revolving Credit Facility and 2018 Second Lien Credit Facility as compared to the second quarter 2018.

**Investment Income:** Investment income relating to investment of the MSA escrow deposits was approximately $0.1 million for the three months ended June 30, 2019 and 2018.

**Loss on extinguishment of debt:** For the three months ended June 30, 2019, there was a loss on the extinguishment of debt for $0.2 million related to the payment on the 2018 Second Lien Credit Facility. For the three months ended June 30, 2018, there was no gain or loss on extinguishment of debt.

**Income Tax Expense:** Our income tax expense of $3.0 million was 18.4% of income before income taxes for the three months ended June 30, 2019 compared to 17.0% for the three months ended June 30, 2018.

**Consolidated Net Income:** Due to the factors described above, consolidated net income for the three months ended June 30, 2019 and 2018, was $13.2 million and $9.3 million, respectively.

#### Comparison of the Six Months Ended June 30, 2019, to the Six Months Ended June 30, 2018

The table and discussion set forth below displays our consolidated results of operations (in thousands):

| Consolidated Results of Operations Data: Net sales | Six Months Ended June 30, 2019 | 2018 | % Change |
| --- | ---: | ---: | ---: |
| Smokeless products | $48,720 | $45,157 | 7.9% |
| Smoking products | 50,882 | 56,324 | -9.7% |
| NewGen products | 85,365 | 53,562 | 59.4% |
| Total net sales | 184,967 | 155,043 | 19.3% |
| Cost of sales | 103,320 | 87,439 | 18.2% |
| Gross profit |  |  |  |
| Smokeless products | 26,136 | 23,526 | 11.1% |
| Smoking products | 27,222 | 28,344 | -4.0% |
| NewGen products | 28,289 | 15,734 | 79.8% |
| Total gross profit | 81,647 | 67,604 | 20.8% |
| Selling, general, and administrative expenses | 49,671 | 43,061 | 15.4% |
| Operating income | 31,976 | 24,543 | 30.3% |
| Interest expense, net | 7,592 | 7,109 | 6.8% |
| Investment income | (262) | (239) | 9.6% |
| Loss on extinguishment of debt | 150 | 2,384 | -93.7% |
| Net periodic benefit (income), excluding service cost | (22) | 221 | -110.0% |
| Income before income taxes | 24,518 | 15,068 | 62.7% |
| Income tax expense | 4,753 | 2,717 | 74.9% |
| Consolidated net income | 19,765 | 12,351 | 60.0% |

**Net Sales:** For the six months ended June 30, 2019, consolidated net sales increased to $185.0 million from $155.0 million for the six months ended June 30, 2018, an increase of $29.9 million or 19.3%. The increase in net sales was primarily driven by volume growth in the NewGen segment which includes an additional four months of Vapor Supply results and two additional quarters of IVG results in 2019, and sales from the newly launched Nu-X alternative products.

For the six months ended June 30, 2019, net sales in the Smokeless products segment increased to $48.7 million from $45.2 million for the six months ended June 30, 2018, an increase of $3.6 million or 7.9% primarily due to the continuing volume growth of *Stoker’s®* MST.

For the six months ended June 30, 2019, net sales in the Smoking products segment decreased to $50.9 million from $56.3 million for the six months ended June 30, 2018, a decrease of $5.4 million or 9.7%. The net sales decline is attributable to the continued delay of Canadian paper orders as a result of new packaging regulations in the country and declining sales in the low-margins cigars business.

For the six months ended June 30, 2019, net sales in the NewGen products segment increased to $85.4 million from $53.6 million for the six months ended June 30, 2018, an increase of $31.8 million or 59.4%. The increase in net sales was primarily driven by $5.1 million of Nu-X alternative products sales year to date and the addition of IVG net sales in 2019.

**Gross Profit:** For the six months ended June 30, 2019, consolidated gross profit increased to $81.6 million from $67.6 million for the six months ended June 30, 2018, an increase of $14.0 million or 20.8%, primarily due to increased net sales. Gross profit as a percentage of revenue increased to 44.1% for the six months ended June 30, 2019, from 43.6% for the six months ended June 30, 2018, primarily due to higher margins in the Smokeless segment from increased MST volume and higher margins in the NewGen segment resulting from the addition of proprietary Nu-X CBD and IVG, a business-to-consumer operation which generally has higher margins.

For the six months ended June 30, 2019, gross profit in the Smokeless products segment increased to $26.1 million from $23.5 million for the six months ended June 30, 2018, an increase of $2.6 million or 11.1%. Gross profit as a percentage of net sales increased to 53.6% of net sales for the six months ended June 30, 2019, from 52.1% of net sales for the six months ended June 30, 2018. The increase in gross profit as a percentage of revenue is primarily due to efficiencies realized in the growing *Stoker’s®* MST line.

For the six months ended June 30, 2019, gross profit in the Smoking products segment decreased to $27.2 million from $28.3 million for the six months ended June 30, 2018, a decrease of $1.1 million or 4.0%. Gross profit as a percentage of net sales increased to 53.5% of net sales for the six months ended June 30, 2019, from 50.3% of net sales for the six months ended June 30, 2018, as a result of the Canadian papers disruption and a continued decline in the low margin cigar business.

For the six months ended June 30, 2019, gross profit in the NewGen products segment increased to $28.3 million from $15.7 million for the six months ended June 30, 2018, an increase of $12.6 million or 79.8%. Gross profit as a percentage of net sales increased to 33.1% of net sales for the six months ended June 30, 2019, from 29.4% of net sales for the six months ended June 30, 2018, primarily as a result of the addition of proprietary Nu-X CBD and IVG, a business-to-consumer operation which generally has higher margins. For the six months ended June 30, 2019, gross profit included $4.0 million of tariff expenses.

**Selling, General, and Administrative Expenses:** For the six months ended June 30, 2019, selling, general, and administrative expenses increased to $49.7 million from $43.1 million for the six months ended June 30, 2018, an increase of $6.6 million or 15.4%, The increase was related to $0.9 million of an additional four months of Vapor Supply, $10.2 million of two quarters of IVG expenses, $1.2 million additional stock option expense, $1.7 million additional new product launch costs for Nu-X products. The increased expenses are partially offset by a net $5.5 million gain related to the settlement of the VMR Distribution and Supply agreement (VMR Agreement) during the second quarter 2019, as well as $0.5 million less of transactional costs. Refer to Note 17, “Legal Settlement”, of Notes to Consolidated Financial Statements for additional information on the settlement.

**Interest Expense, net:** For the six months ended June 30, 2019, interest expense increased to $7.6 million from $7.1 million for the six months ended June 30, 2018, as a result of higher interest rates in 2019 for the 2018 Revolving Credit Facility and 2018 Second Lien Credit Facility as compared to 2018.

**Investment Income:** Investment income relating to investment of the MSA escrow deposits increased to $0.3 million for the six months ended June 30, 2019, compared to $0.2 million for the six months ended June 30, 2018.

**Loss on Extinguishment of Debt:** For the six months ended June 30, 2019, loss on extinguishment of debt was $0.2 million as the result of the payment on the 2018 Second Lien Credit Facility. For the six months ended June 30, 2018, loss on extinguishment of debt was $2.4 million as a result of refinancing our credit facility in the first quarter of 2018.

**Income Tax Expense:** Our income tax expense of $4.8 million was 19.4% of income before income taxes for the six months ended June 30, 2019, compared to 18.0% for the six months ended June 30, 2018. Our income tax expense for the six months ended June 30, 2018 is lower than expected based on our estimated annual effective tax rate as a result of discrete tax deductions of $4.5 million from the exercise of stock options during the six-month period.

**Consolidated Net Income:** Due to the factors described above, consolidated net income for the six months ended June 30, 2019 and 2018, was $19.8 million and $12.4 million, respectively.

### EBITDA and Adjusted EBITDA

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our credit agreements contain financial covenants which use Adjusted EBITDA calculations.

We define “EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider ordinary course in our evaluation of ongoing operating performance.

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.

*(in thousands)*

|  | Three Months Ended June 30, 2019 | 2018 |
| --- | ---: | ---: |
| Consolidated net income | $13,205 | $9,319 |
| Add: |  |  |
| Interest expense, net | 3,736 | 3,455 |
| Loss on extinguishment of debt | 150 | - |
| Income tax expense | 2,979 | 1,908 |
| Depreciation expense | 632 | 557 |
| Amortization expense | 364 | 176 |
| EBITDA | $21,066 | $15,415 |
| Components of Adjusted EBITDA |  |  |
| Other (a) | (97) | 244 |
| Stock options, restricted stock, and incentives expense (b) | 1,198 | 492 |
| Transactional expenses and strategic initiatives (c) | 187 | 1,030 |
| New product launch costs (d) | 1,270 | - |
| Severance charges and organizational development (e) | 150 | 44 |
| Vendor settlement (f) | (5,522) | - |
| Adjusted EBITDA | $18,252 | $17,225 |

(a) Represents LIFO adjustment, non-cash pension/ postretirement expense (income) and foreign exchange hedging.

(b) Represents non-cash stock options, restricted stock and incentives expense.

(c) Represents the fees incurred for transaction expenses and strategic initiatives.

(d) Represents product launch costs of our new product lines.

(e) Represents costs associated with departmental restructuring, including severance.

(f) Represents net gain associated with the settlement of a vendor contract.

*(in thousands)*

|  | Six Months Ended June 30, 2019 | 2018 |
| --- | ---: | ---: |
| Consolidated net income | $19,765 | $12,351 |
| Add: |  |  |
| Interest expense, net | 7,592 | 7,109 |
| Loss on extinguishment of debt | 150 | 2,384 |
| Income tax expense | 4,753 | 2,717 |
| Depreciation expense | 1,163 | 1,117 |
| Amortization expense | 723 | 351 |
| EBITDA | $34,146 | $26,029 |
| Components of Adjusted EBITDA |  |  |
| Other (a) | (176) | 216 |
| Stock options, restricted stock, and incentives expense (b) | 1,913 | 689 |
| Transactional expenses and strategic initiatives (c) | 1,097 | 1,629 |
| New product launch costs (d) | 1,712 | 682 |
| Product line rationalizations (e) | - | 1,008 |
| Warehouse reorganization (f) | 508 | - |
| Severance charges and organizational development (g) | 646 | 680 |
| Vendor settlement (h) | (5,522) | - |
| Adjusted EBITDA | $34,324 | $30,933 |

(a) Represents LIFO adjustment, non-cash pension/ postretirement expense (income) and foreign exchange hedging.

(b) Represents non-cash stock options, restricted stock and incentives expense.

(c) Represents the fees incurred for transaction expenses and strategic initiatives.

(d) Represents product launch costs of our new product lines.

(e) Represents costs associated with discontiued products related to product line rationalization.

(f) Represents costs associated with consolidating warehouses.

(g) Represents costs associated with departmental restructuring, including severance.

(h) Represents net gain associated with the settlement of a vendor contract.

### Liquidity and Capital Reserves

Our principal uses for cash are working capital, debt service, and capital expenditures. We believe our cash flows from operations and borrowing availability under our 2018 Revolving Credit Facility are adequate to satisfy our operating cash requirements for the foreseeable future.

Our working capital, which we define as current assets less current liabilities, increased $5.2 million to $53.3 million at June 30, 2019, compared with $48.1 million at December 31, 2018. The increase in working capital is primarily due to increased accounts receivable.

*(in thousands)*

|  | As of June 30, 2019 | December 31, 2018 |
| --- | ---: | ---: |
| Current assets | $121,174 | $111,854 |
| Current liabilities | 67,910 | 63,766 |
| Working capital | $53,264 | $48,088 |

41

#### Cash Flows from Operating Activities

For the six months ended June 30, 2019, net cash provided by operating activities was $21.7 million compared to net cash provided by operating activities of $6.0 million for the six months ended June 30, 2018, an increase of $15.8 million, primarily due to changes in working capital accounts.

#### Cash Flows from Investing Activities

For the six months ended June 30, 2019, net cash used in investing activities was $0.3 million compared to net cash used in investing activities of $14.0 million for the six months ended June 30, 2018, a decrease of $13.7 million, primarily due to the issuance of $6.5 million note receivable and the acquisition of Vapor Supply in 2018.

#### Cash Flows from Financing Activities

For the six months ended June 30, 2019, net cash used in financing activities was $20.9 million compared to net cash provided by financing activities of $6.1 million for the six months ended June 30, 2018, a decrease of $27.0 million, primarily due to payments on debt in 2019, whereas refinancing activities in 2018 provided cash inflow.

#### Dividends

On November 9, 2017, our Board of Directors approved the initiation of a cash dividend to shareholders. The initial quarterly dividend of $0.04 per common share was paid on December 15, 2017, to shareholders of record at the close of business on November 27, 2017. The most recent dividend of $0.045 per common share was paid on July 12, 2019, to shareholders of record at the close of business on June 21, 2019.

### Long-Term Debt

As of June 30, 2019, we were in compliance with the financial and restrictive covenants of the 2018 Credit Facility. The following table provides outstanding balances of our debt instruments.

|  | June 30, 2019 | December 31, 2018 |
| --- | ---: | ---: |
| 2018 Revolving Credit Facility | $15,000 | $26,000 |
| 2018 First Lien Term Loan | 150,000 | 154,000 |
| 2018 Second Lien Term Loan | 35,511 | 40,000 |
| Note payable - IVG | 4,000 | 4,000 |
| Total notes payable and long-term debt | 204,511 | 224,000 |
| Less deferred finance charges | (2,909) | (3,285) |
| Less revolving credit facility | (15,000) | (26,000) |
| Less current maturities | (13,000) | (8,000) |
|  | $173,602 | $186,715 |

#### 2018 Credit Facility

The 2018 Credit Facility contains customary events of default including payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to certain other material indebtedness in excess of specified amounts, certain events of bankruptcy and insolvency, certain ERISA events, judgments in excess of specified amounts, and change in control defaults. The 2018 Credit Facility also contains certain negative covenants customary for facilities of these types including covenants that, subject to exceptions described in the 2018 Credit Facility, restrict our ability: (i) to pledge assets, (ii) to incur additional indebtedness, (iii) to pay dividends, (iv) to make distributions, (v) to sell assets, and (vi) to make investments. Refer to Note 20, “Dividends”, of Notes to Consolidated Financial Statements for further information regarding dividend restrictions.

**2018 First Lien Credit Facility:** The 2018 First Lien Term Loan and the 2018 Revolving Credit Facility bear interest at LIBOR plus a spread of 2.75% to 3.50% based on our senior leverage ratio. The 2018 First Lien Term Loan has quarterly required payments of $2.0 million beginning June 30, 2018, increasing to $3.0 million on June 30, 2020, and increasing to $4.0 million on June 30, 2022. The 2018 First Lien Credit Facility has a maturity date of March 7, 2023. The 2018 First Lien Term Loan is secured by a first priority lien on substantially all of the assets of the borrowers and the guarantors thereunder, including a pledge of our capital stock, other than certain excluded assets (the “Collateral”). The 2018 First Lien Credit Facility contains certain financial covenants including maximum senior leverage ratio of 3.50x with step-downs to 3.00x, a maximum total leverage ratio of 4.50x with step-downs to 4.00x, and a minimum fixed charge coverage ratio of 1.20x. Based on an excess cash covenant for the facility, a principal payment of $4.5 million was due in the second quarter 2019. All parties agreed to waive the payment, resulting in consent fees of $0.1 million. The weighted average interest rate of the 2018 First Lien Term Loan was 5.40% at June 30, 2019. The weighted average interest rate of the 2018 Revolving Credit Facility was 5.54% at June 30, 2019. At June 30, 2019, we had $15.0 million of borrowings outstanding under the 2018 Revolving Credit Facility. The $35.0 million unused portion of the 2018 Revolving Credit Facility is reduced by letters of credit from Fifth Third Bank totaling $1.8 million, resulting in $33.2 million of availability under the 2018 Revolving Credit Facility at June 30, 2019. See “Recent Developments” for further information on amendments for the facility.

**2018 Second Lien Credit Facility:** The 2018 Second Lien Credit Facility bears interest at a rate of LIBOR plus 7.00% and has a maturity date of March 7, 2024. The 2018 Second Lien Term Loan is secured by a second priority interest in the Collateral and is guaranteed by the same entities as the 2018 First Lien Term Loan. The 2018 Second Lien Credit Facility contains certain financial covenants including a maximum senior leverage ratio of 3.75x with step-downs to 3.50x, a maximum total leverage ratio of 4.75x with step-downs to 4.50x, and a minimum fixed charge coverage ratio of 1.10x. Based on an excess cash covenant for the facility, a $4.5 million principal payment was made in the second quarter 2019, resulting in $0.2 million loss on extinguishment of debt. The weighted average interest rate on the remaining $35.5 million balance of the 2018 Second Lien Term Loan was 9.40% at June 30, 2019.

#### Note Payable – IVG

In September 2018, we issued a note payable to IVG’s former shareholders (“IVG Note”). The IVG Note is $4.0 million principal with 6.0% interest compounding annually and matures on March 5, 2020. All principal and accrued and unpaid interest under the IVG Note is subject to indemnification obligations of the sellers pursuant to the International Vapor Group Stock Purchase Agreement dated as of September 5, 2018.

### Off-balance Sheet Arrangements

During the first and second quarters of 2019 we did not execute any forward contracts. During 2018 the Company executed various forward contracts, none of which met hedge accounting requirements, for the purchase of €14.5 million with maturity dates ranging from March 2018 to January 2019. At June 30, 2019, and December 31, 2018, we had forward contracts for the purchase of €0.0 million and €1.5 million, respectively.

### Inflation

We believe that any effect of inflation at current levels will be minimal. Historically, we have been able to increase prices at a rate equal to or greater than that of inflation and believe that we will continue to be able to do so for the foreseeable future. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our successful procurement with regard to our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.

## Market risk

As filed, 1,638 characters.

### Foreign Currency Sensitivity

There have been no material changes in our exposure to exchange rate fluctuation risk, as reported within our 2018 Annual Report on Form 10-K, during the period. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2018 Annual Report on Form 10-K filed with the SEC.

### Credit Risk

There have been no material changes in our exposure to credit risk, as reported within our 2018 Annual Report on Form 10-K, during the three months ended June 30, 2019. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2018 Annual Report on Form 10-K filed with the SEC.

### Interest Rate Sensitivity

Our March 2018 refinancing resulted in all of our long-term debt instruments having variable interest rates that fluctuate with market rates. To reduce the volatility of future cash flows, we entered into interest rate swap agreements with lenders under the 2018 Credit Facility in March 2018. At June 30, 2019, $70 million of our outstanding long-term debt carrying variable rates is covered by the interest rate swap agreements and, thus, effectively bears interest at a fixed rate. We believe the effect, if any, of reasonably possible near-term changes in interest rates on our consolidated financial position, results of operations, or cash flows would not be significant. A 1% increase in the interest rate would change pre-tax income by approximately $1.3 million per year. Refer to Note 4, “Derivative Instruments”, of Notes to Consolidated Financial Statements for additional information regarding the interest rate swaps.

## Controls and procedures

As filed, 1,320 characters.

We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended (the “Act”)) as of June 30, 2019. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by us in the reports we file or submit under the Act is: (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosures.

There have been no changes in the Company’s internal control over financial reporting during the most recent fiscal quarter which have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 1,965 characters.

In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our 2018 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2018 Annual Report on Form 10-K with the exception of the following update for the risk factor “Some of our products are subject to developing and unpredictable regulation”:

Some of our NewGen products marketed through our Nu-X subsidiary and similar third-party products sold through our NewGen distribution vehicles may be subject to uncertain federal, state and local regulations concerning hemp, CBD and other non-tobacco consumable products. Enforcement initiatives by those authorities are therefore unpredictable and impossible to anticipate. We anticipate that all levels of government are likely to seek in some way to regulate these products, but the type, timing, and impact of such regulations remains uncertain. Accordingly, we cannot give any assurance that such actions would not have a material adverse effect on this emerging business.

We currently and plan in the future to commercialize in the United States a variety of products containing hemp-derived CBD. While the Agriculture Improvement Act of 2018, or the Farm Bill, exempted hemp and hemp-derived products from the Controlled Substances Act, or the CSA, any such product commercialization may become subject to various laws, including the Farm Bill, the Food, Drug and Cosmetic Act, or the FD&CA, the Dietary Supplement Health and Education Act, or DSHEA, applicable state and/or local laws, and FDA regulations. We intend to offer hemp-derived CBD products in full compliance with laws and regulations. Nevertheless, violations of any such law or regulation could result in warning letters, significant fines, penalties, administrative sanctions, injunctions, convictions or settlements arising from civil proceedings initiated.

Filed Aug 1, 2019.
Source: SEC EDGAR, the filing index for accession 0001140361-19-013997. Last ingested by Listed: Nov 10, 2026, 02:39 ET. No prices; not investment advice.
